Lymphoscintigraphy to confirm the clinical diagnosis of lymphedema Peter J. Golueke, MD, Robert A. Montgomery, MD, John D. Petronis, MD *, Stanley L. Minken, MD, Bruce A. Perler, MD, G.Melville Williams, MD  Journal of Vascular Surgery  Volume 10, Issue 3, Pages 306-312 (September 1989) DOI: 10.1016/0741-5214(89)90446-1 Copyright © 1989 Society for Vascular Surgery and International Society for Cardiovascular Surgery North American Chapter Terms and Conditions

Fig. 1 Normal lymphoscintigram. A, Marked radioactivity at site of injection of radiotracer in both feet, with lymph channels ascending calf. Marker in midcalf region (arrow). B, Iliac region shows iliac and femoral nodes bilaterally. C, Paraaortic nodes and normal liver activity 3 hours after injection. (Note: Extremity scans usually separated by 24- to 48-hour interval to evaluate hepatic uptake individually by each limb injection.) Journal of Vascular Surgery 1989 10, 306-312DOI: (10.1016/0741-5214(89)90446-1) Copyright © 1989 Society for Vascular Surgery and International Society for Cardiovascular Surgery North American Chapter Terms and Conditions

Fig. 2 Photograph and lymphoscintigram of patient with lymphedema praecox. A, Front view shows involvement of right leg. B, Scintiscan of right lateral foot shows absence of normal lymphatic channels, with moderate dermal backflow; marked tracer activity at injection site (arrow). C, No lymphatic channels noted in right knee region; note knee marker (arrow). D, No lymph channels or inguinal nodes (large arrow) in right groin region; note bladder activity (small arrow). E, Abdomen scan 3 hours after injection of radiotracer in right foot; no liver tracer activity noted. Journal of Vascular Surgery 1989 10, 306-312DOI: (10.1016/0741-5214(89)90446-1) Copyright © 1989 Society for Vascular Surgery and International Society for Cardiovascular Surgery North American Chapter Terms and Conditions